These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4009219)

  • 1. Phase I trial of N-methylformamide (NMF, NSC 3051).
    O'Dwyer PJ; Donehower M; Sigman LM; Fortner CL; Aisner J; Van Echo DA
    J Clin Oncol; 1985 Jun; 3(6):853-7. PubMed ID: 4009219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of N-methylformamide (NMF) administered orally on a three times weekly schedule: a phase I study.
    Rowinsky EK; Grochow LB; Hantel A; Ettinger DS; Vito BL; Donehower RC
    Invest New Drugs; 1989 Nov; 7(4):317-25. PubMed ID: 2599802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study of N-methylformamide in patients with advanced cancer.
    Ettinger DS; Orr DW; Rice AP; Donehower RC
    Cancer Treat Rep; 1985 May; 69(5):489-93. PubMed ID: 4005871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I trial of N-methylformamide.
    McVie JG; ten Bokkel Huinink WW; Simonetti G; Dubbelman R
    Cancer Treat Rep; 1984 Apr; 68(4):607-10. PubMed ID: 6325001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of N-methylformamide in advanced head and neck cancer.
    Vogel WC; Forastiere AA; Natale RB; Takasugi BJ; Schnur G
    Invest New Drugs; 1987; 5(2):203-6. PubMed ID: 3654153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of N-methylformamide in patients with metastatic melanoma.
    Eton O; Bajorin DF; Casper ES; Houghton AN
    Invest New Drugs; 1991 Feb; 9(1):97-100. PubMed ID: 2026491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacology of oral and i.v. N-methylformamide: a pharmacologic basis for lack of clinical antineoplastic activity.
    Rowinsky EK; Noe DA; Orr DW; Grochow LB; Ettinger DS; Donehower RC
    J Natl Cancer Inst; 1988 Jul; 80(9):671-8. PubMed ID: 3373556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-methylformamide: cytotoxic, radiosensitizer, or chemosensitizer.
    Clagett-Carr K; Sarosy G; Plowman J; Hoth DF; Leyland-Jones B
    J Clin Oncol; 1988 May; 6(5):906-18. PubMed ID: 3284976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Methylformamide in advanced squamous cancer of the uterine cervix: an Eastern Cooperative Oncology Group phase II trial.
    Rajdev L; Yu ZF; Wadler S; Weller E; Kahn SB; Tormey D; Skeel R; Wiernik PH
    Invest New Drugs; 2001; 19(3):233-7. PubMed ID: 11561680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of N-methylformamide for advanced renal cell carcinoma.
    Sternberg CN; Yagoda A; Scher HI; Hollander P
    Cancer Treat Rep; 1986 May; 70(5):681-2. PubMed ID: 3708620
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II trial of N-methylformamide in advanced renal cancer.
    Abrams JS; Tait N; Silva H; Eisenberger M; Van Echo DA; Olver IN; Aisner J
    Am J Clin Oncol; 1989 Feb; 12(1):41-2. PubMed ID: 2912020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicity of oral N-methylformamide in three phase II trials: a report from the National Cancer Institute of Canada Clinical Trials Group.
    Eisenhauer EA; Weinerman BH; Kerr I; Quirt I
    Cancer Treat Rep; 1986 Jul; 70(7):881-3. PubMed ID: 3719579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I evaluation of the quinazoline antifolate thymidylate synthase inhibitor, N10-propargyl-5,8-dideazafolic acid, CB3717.
    Calvert AH; Alison DL; Harland SJ; Robinson BA; Jackman AL; Jones TR; Newell DR; Siddik ZH; Wiltshaw E; McElwain TJ
    J Clin Oncol; 1986 Aug; 4(8):1245-52. PubMed ID: 3734849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of Datelliptium chloride, hydrochloride given by 24-h continuous intravenous infusion.
    Khayat D; Borel C; Azab M; Paraisot D; Malaurie E; Bouloux C; Weil M
    Cancer Chemother Pharmacol; 1992; 30(3):226-8. PubMed ID: 1628372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I clinical and pharmacokinetic trial of Brequinar sodium (DuP 785; NSC 368390).
    Arteaga CL; Brown TD; Kuhn JG; Shen HS; O'Rourke TJ; Beougher K; Brentzel HJ; Von Hoff DD; Weiss GR
    Cancer Res; 1989 Aug; 49(16):4648-53. PubMed ID: 2743343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I and pharmacokinetic study of Col-3 (Metastat), an oral tetracycline derivative with potent matrix metalloproteinase and antitumor properties.
    Syed S; Takimoto C; Hidalgo M; Rizzo J; Kuhn JG; Hammond LA; Schwartz G; Tolcher A; Patnaik A; Eckhardt SG; Rowinsky EK
    Clin Cancer Res; 2004 Oct; 10(19):6512-21. PubMed ID: 15475438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I clinical and pharmacological study of merbarone.
    Dimaggio JJ; Warrell RP; Muindi J; Stevens YW; Lee SJ; Lowenthal DA; Haines I; Walsh TD; Baltzer L; Yaldaei S
    Cancer Res; 1990 Feb; 50(4):1151-5. PubMed ID: 2297763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neck.
    Forastiere AA; Natale RB; Takasugi BJ; Goren MP; Vogel WC; Kudla-Hatch V
    J Clin Oncol; 1987 Feb; 5(2):190-6. PubMed ID: 3543242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus-directed, enzyme prodrug therapy with nitroimidazole reductase: a phase I and pharmacokinetic study of its prodrug, CB1954.
    Chung-Faye G; Palmer D; Anderson D; Clark J; Downes M; Baddeley J; Hussain S; Murray PI; Searle P; Seymour L; Harris PA; Ferry D; Kerr DJ
    Clin Cancer Res; 2001 Sep; 7(9):2662-8. PubMed ID: 11555577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I, first in man study of OSI-7836 in patients with advanced refractory solid tumors: IND.147, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group.
    Goss G; Siu LL; Gauthier I; Chen EX; Oza AM; Goel R; Maroun J; Powers J; Walsh W; Maclean M; Drolet DW; Rusk J; Seymour LK;
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):703-10. PubMed ID: 16528532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.